FQHCs have potential to diversify clinical trials for hypertension and T2D but show limited engagement, mostly at low levels. The review analyzed 33 trials involving 67 FQHCs, with few demonstrating ...

A trial of 648 patients found that the new automated method and intervention strategy resulted in nearly four times as many diagnoses and treatment plans for high blood pressure compared with ...

Lorundrostat, a novel therapy which blocks the production of aldosterone from the adrenal glands, demonstrated clinically meaningful and sustained reductions in blood pressure in 1,083 patients with ...

A new study by investigators at Mass General Brigham shows that clues about hypertension may be buried in electronic health records (EHR). Using natural language processing, a form of artificial ...